Literature DB >> 1537350

Recombinant human interferon-gamma treatment in severe leucocyte adhesion deficiency.

R S Weening1, R G Bredius, P P Vomberg, C E van der Schoot, M Hoogerwerf, D Roos.   

Abstract

We describe a patient with leucocyte adhesion deficiency (LAD). Clinically, the patient had delayed umbilical cord detachment, omphalitis, impaired wound healing and persistent leucocytosis. The patient had the severe form of LAD, with a total absence of leucocyte cell adhesion molecules (LeuCAMs) and undetectable mRNA for the beta chain, the common subunit of the LeuCAMs. In vitro neutrophil chemotaxis, aggregation and oxygen consumption were severely impaired. In vitro incubation of neutrophils with recombinant human interferon-gamma (rIFN-gamma) showed an increase in oxygen consumption, but no effect on the expression of the LeuCAMs, or the beta chain mRNA. In vivo treatment with IFN-gamma was started. The Fc gamma RI receptor appeared on the neutrophils, the LeuCAMs remained undetectable, while the neutrophil functions remained disturbed. The patient died of surgical complications after 10 weeks of rIFN-gamma treatment. No new infections or side-effects due to rIFN-gamma were observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537350     DOI: 10.1007/bf01958952

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

Authors:  R A Ezekowitz; S H Orkin; P E Newburger
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.

Authors:  K C Petroni; L Shen; P M Guyre
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

3.  Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency.

Authors:  D Roos; R S Weening; A A Voetman; M L van Schaik; A A Bot; L J Meerhof; J A Loos
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

4.  Effects of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) on the expression of LFA-1 in the moderate phenotype of leukocyte adhesion deficiency (LAD).

Authors:  M T Dimanche-Boitrel; F Le Deist; A Quillet; A Fischer; C Griscelli; B Lisowska-Grospierre
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

5.  Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency.

Authors:  T K Kishimoto; N Hollander; T M Roberts; D C Anderson; T A Springer
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

6.  The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features.

Authors:  D C Anderson; F C Schmalsteig; M J Finegold; B J Hughes; R Rothlein; L J Miller; S Kohl; M F Tosi; R L Jacobs; T C Waldrop
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

7.  Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.

Authors:  T A Springer; W S Thompson; L J Miller; F C Schmalstieg; D C Anderson
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

8.  Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosis.

Authors:  A Fischer; P H Trung; B Descamps-Latscha; B Lisowska-Grospierre; I Gerota; N Perez; C Scheinmetzler; A Durandy; J L Virelizier; C Griscelli
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

9.  Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation.

Authors:  A Fischer; C Griscelli; S Blanche; F Le Deist; F Veber; M Lopez; M Delaage; D Olive; C Mawas; G Janossy
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

10.  A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.

Authors:  F Sanchez-Madrid; J A Nagy; E Robbins; P Simon; T A Springer
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.